SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the June 2022 quarter is pegged at Rs. 2715.22 millions, about 12.18% up against Rs. 2420.50 millions recorded during the year-ago period.Profit saw a slight increase of 7.40%to Rs. 201.38  millions from Rs. 187.51 millions.The company reported a good operating profit of 603.76 millions compared to 570.10 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 2715.22 2420.50 12.18 2715.22 2420.50 12.18 9880.90 8565.78 15.35
Other Income 73.90 63.68 16.05 73.90 63.68 16.05 417.16 231.28 80.37
PBIDT 603.76 570.10 5.90 603.76 570.10 5.90 2361.90 2036.24 15.99
Interest 239.77 241.24 -0.61 239.77 241.24 -0.61 955.33 1002.16 -4.67
PBDT 363.99 328.86 10.68 363.99 328.86 10.68 1389.65 1034.08 34.39
Depreciation 162.61 140.57 15.68 162.61 140.57 15.68 1309.70 872.92 50.04
PBT 201.38 188.29 6.95 201.38 188.29 6.95 79.95 161.16 -50.39
TAX 0.00 0.78 0.00 0.00 0.78 0.00 137.05 205.16 -33.20
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -109.17 94.76 -215.21
PAT 201.38 187.51 7.40 201.38 187.51 7.40 -57.10 -44.00 29.77
Equity 590.87 590.87 0.00 590.87 590.87 0.00 590.87 590.87 0.00
PBIDTM(%) 22.24 23.55 -5.59 22.24 23.55 -5.59 23.90 23.77 0.55

Ind-Swift Lab. Share Price

132.00 -13.30 (-9.15%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×